New Leaf Venture Partners, L.L.C. - HARPOON THERAPEUTICS INC ownership

HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 70 filers reported holding HARPOON THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
New Leaf Venture Partners, L.L.C. ownership history of HARPOON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,272,142
-43.2%
315,668
-90.0%
1.63%
-15.1%
Q2 2023$2,241,256
-4.1%
3,156,6990.0%1.92%
-0.3%
Q1 2023$2,335,957
+2.0%
3,156,6990.0%1.93%
+16.4%
Q4 2022$2,290,816
-25.2%
3,156,6990.0%1.66%
-8.8%
Q3 2022$3,062,000
-49.2%
3,156,6990.0%1.82%
-53.5%
Q2 2022$6,029,000
-61.6%
3,156,6990.0%3.91%
-49.5%
Q1 2022$15,689,000
-34.2%
3,156,6990.0%7.73%
-10.5%
Q4 2021$23,833,000
-4.4%
3,156,6990.0%8.64%
+20.0%
Q3 2021$24,938,000
+641.3%
3,156,6990.0%7.19%
+733.5%
Q2 2021$3,364,000
-94.9%
3,156,6990.0%0.86%
-94.4%
Q1 2021$66,038,000
+36.1%
3,156,699
+8.1%
15.37%
+37.1%
Q4 2020$48,525,000
-2.2%
2,921,4050.0%11.21%
-43.9%
Q3 2020$49,635,000
+2.4%
2,921,4050.0%20.00%
+43.7%
Q2 2020$48,495,000
+43.3%
2,921,4050.0%13.92%
+37.5%
Q1 2020$33,830,000
-21.7%
2,921,4050.0%10.12%
+7.8%
Q4 2019$43,208,000
+8.3%
2,921,4050.0%9.39%
-22.2%
Q3 2019$39,906,000
+5.1%
2,921,4050.0%12.07%
+18.6%
Q2 2019$37,978,000
+37.3%
2,921,4050.0%10.18%
+34.3%
Q1 2019$27,666,0002,921,4057.58%
Other shareholders
HARPOON THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 3,156,699$2,335,9571.93%
MPM ASSET MANAGEMENT LLC 3,131,388$2,329,7530.97%
MPM BioImpact LLC 3,196,707$2,378,3500.62%
Lion Point Capital, LP 169,283$125,9800.05%
Artal Group S.A. 1,000,000$7440.04%
Cormorant Asset Management, LP 540,600$4020.03%
KENNEDY CAPITAL MANAGEMENT LLC 529,934$394,3770.01%
Orbimed Advisors 621,218$462,3100.01%
Tekla Capital Management LLC 259,910$193,4250.01%
CM WEALTH ADVISORS LLC 50,354$290.01%
View complete list of HARPOON THERAPEUTICS INC shareholders